Roswell Park Takes in New Research Funding

Roswell Park received more than $21.8 million in recent competitive grants and contracts to launch new investigations or continue major research efforts that have shown promise. This includes funding from the National Cancer Institute (NCI) Cancer Moonshot program as well as multimillion-dollar renewals for high-impact projects based

Read more

New York Women Power 100 Honors Roswell Park Leaders

Roswell Park Comprehensive Care Center

Media company City & State has recognized Roswell Park President and CEO Candace S. Johnson, PhD, and Board of Directors member Leecia Eve, JD, for their leadership and accomplishments, naming them to its annual New York Women Power 100 list. ImageCity & State, which covers government and

Read more

Clinical Trial for Brain Cancer Glioblastoma Immunotherapy SurVaxM

Roswell Park Spinoff Company Advances Toward New Clinical Trial for Brain Cancer Immunotherapy SurVaxM MimiVax LLC and Roswell Park to launch large clinical trial at centers in U.S. & abroad following major licensing deal MimiVax LLC secures $10 million upfront in licensing deal Large phase II studies expected

Read more